Société Générale — Capital/Financing Update 2025

Nov 11, 2025

National Storage Mechanism | Additional information

RNS Number : 1199H

Societe Generale SA

11 November 2025

11th November 2025

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

alstria office AG

Post-stabilisation Period Announcement

Societe Generale (contact: Alain Stalker +44 20 3547 1538) gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) [as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018]) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

Securities
Issuer:	alstria office AG
Guarantor(s) (if any):	N/A
Aggregate nominal amount:	EUR 500mm WNG
Description:	Coupon: 4.25% Maturity: 15/10/2029
Offer price:	99.103
Stabilisation:
Stabilisation Manager(s)	SG CIB
Stabilisation period expected to start on	08/10/2025
Stabilisation period expected to end no later than	14/11/2025
Existence, maximum size and conditions of use of over‑allotment facility:	The Stabilisation Manager(s) may over‑allot the securities to the extent permitted in accordance with applicable law.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

STAFFIFMFEISEEF